Search results
Psoriasis study shows high level of arthritis symptoms in patients
Medical Xpress· 5 days agoThe study led by researchers at the Universities of Oxford, University College Dublin and supported...
Barstool's Dave Portnoy had basal cell carcinoma removed. Experts explain the skin cancer's risks,...
Yahoo Life Style via AOL· 3 days agoSkin Cancer Foundation warns readers that BCCs can resemble noncancerous skin conditions like ...
9 Face-Lifting Skincare Products Dermatologists Recommend For Fast, Visible Results This Summer
SheFinds via Yahoo News· 3 days agoIf you’ve become aware of the onset of fine lines and wrinkles or have been considering the...
Why Is My Skin So Itchy?
Verywell Health via Yahoo News· 5 days agoPruritus, or itchy skin, is a characteristic feature of many skin diseases and an unusual sign of some systemic diseases. It can be painful or...
States struggle to help patients navigate insurance hurdle known as ‘step therapy’
North Dakota Monitor via Yahoo News· 7 hours agoCassidy Yermal, 32, began experiencing debilitating migraines when she was 17 years old. As a...
How To Get Rid Of (And Prevent) Chin Acne
Women's Health via Yahoo News· 5 days agoChin acne can be caused by your diet, hygiene practices, hormones, and plenty of other factors. Experts explain how to fight and prevent it in the first...
13 Best Shampoos for Thinning Hair, According to Hair and Skin Experts
Prevention via AOL· 3 days agoWe reviewed the best shampoos for thinning hair, per dermatologists. Our top picks reign from brands...
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
Morningstar· 5 days agoApproval supported by two Phase 3 clinical trials that evaluated SKYRIZI® for the treatment of moderate to severe ulcerative colitis: a 12-week induction study, INSPIRE,1 ...
Polycystic Ovarian Syndrome: New Science Offers Old Remedy
Medscape· 5 days agoAn ancient Chinese remedy for malaria could offer new hope to the 10% of reproductive-age women...
Johnson & Johnson submits application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the ...
Morningstar· 3 days agoFood and Drug Administration (FDA) seeking approval of TREMFYA® (guselkumab) for the treatment of adults with moderately to severely active Crohn's disease. The submission ...